Vital Therapies (VTL) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts VTL Hot Sheet
Join SI Premium – FREE
Vital Therapies (NASDAQ: VTL) reported Q2 EPS of ($0.29), $0.06 better than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Vital Therapies (VTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- The LGL Group (LGL) Misses Q2 EPS by 8c
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
